19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)-
-
19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)-
structure -
-
CAS No:
100938-11-2
-
Formula:
C30H46O16S2.2Na
-
Chemical Name:
19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)-
-
Synonyms:
19-Norkaur-16-en-18-oic acid,15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-,disodium salt,(2β,4α,15α)-;1H-2,10a-Ethanophenanthrene,19-norkaur-16-en-18-oic acid deriv.
- Categories:
-
CAS No:
19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)- Basic Attributes
770.77
770.18700
Safety Information
I
6.1(a)
3172
23/24/25
36/37/39-45
T
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P311, P312, P321, P322, P330, P361, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)- Use and Manufacturing
A specific inhibitor of the adenine nucleotide translocase (ANT), which is a mitochondrial ADP/ATP carrier. It is also a proapoptotic ligand of ANT that induces pore formation by ANT, and results in permeabilization of the mitochondria membrane. Studies on rat hearts suggest that Atractyloside inhibits chloride channels from the mitochondrial membrane. It is used to probe the source of procaspase 8 in human fibroblasts and mouse clonal striatal cells, as related to death receptor-mediated apoptosis. Atractyloside induces the release of ahyaluronidase-induced murine WW domain-containing oxidoreductase from cultured COS-7 cells, with respect to tumor necrosis factor cytotoxicity.
Computed Properties
Molecular Weight:770.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:16
Rotatable Bond Count:10
Exact Mass:770.18661622
Monoisotopic Mass:770.18661622
Topological Polar Surface Area:272
Heavy Atom Count:50
Complexity:1440
Defined Atom Stereocenter Count:12
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
9-Octadecenoic acid, 12-hydroxy(sulfooxy)-, 1-butyl ester, disodium salt, [R-(Z)]-
71873-02-4
-
Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[(4-aminophenyl)sulfonyl]amino]-, disodium salt, reaction products with 3,4-dichlorobenzenesulfonyl chloride
90218-36-3
-
Butanedioic acid, 2,3-bis(benzoyloxy)-, disodiuM salt, [R-(R*,R*)]-
123781-93-1
-
Zoledronic Acid, Disodium Salt, Tetrahydrate Formula
165800-07-7
-
7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid, disodium salt, mixt. with 1-methylethyl phenylcarbamate Formula
8015-38-1
-
2-Butenedioic acid, 2-methyl-3-tetradecyl-, disodium salt, (2Z)- Formula
161308-35-6
-
Sulfurous acid, monosodium salt, reaction products with bisphenol A disodium salt and formaldehyde Structure
90583-38-3
-
Selenic acid, disodium salt, decahydrate Structure
10102-23-5
-
What is Phosphoric acid, disodium salt, compd. with 2-aminoethanol (1:1)
53404-45-8
-
What is 19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, potassium salt (1:2), (2β,15α)-
102130-43-8
19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, disodium salt, (2β,4α,15α)-
SDSRequest for Quotation